DLA Piper partners Ellen Scordino and Susan Krumplitsch are joined by Duane Valz, General Counsel of Insitro, to discuss how machine learning is being used to generate and leverage data for the development of better medicines.
At the Intersection of Science and Law
13 clip(s)
Life sciences companies and the risks posed by the mifepristone litigation
Trade secrets protection in the life sciences sector
Cross-border considerations for privacy in clinical trials